Table of Contents
EXECUTIVE SUMMARY
A detailed and comprehensive overview of current financial position, company
strategy, product and pipeline analysis.
THERAPEUTIC AREA FOCUS
- Key product analysis and forecasting
- CardioMetabolic Care
- Physiotens/Cynt (moxonidine)
- Teveten (eprosartan mesylate)
- TriCor/Lipanthyl (fenofibrate)
- Women' s and Men' s Health
- AndroGel/Andractim (dihydro testosterone)
- Estratest (esterified oestrogens)
- Neuroscience
- Duodopa (levodopa+carbidopa)
- Luvox (fluvoxamine)
- Marinol (dronabinol)
- Serc/Betaserc (betahistine)
- Gastroenterology
- Duphalac (laxative lactulose)
- Pancreatic Enzymes
- Creon (porcine pancreatin supplement)
- Influenza Vaccines
- Influvac (inactivated influenza surface antigen)
- Invivac
OPERATIONAL DATA
- A wealth of background and detail
- A full 5-year financial performance assessment
- Key agreements
- Infrastructure
- Subsidiaries and joint ventures
| 
View Cart
